Tuesday, August 4, 2009

Allergan now touted as a takeover target

I touted Allergan at 52.75 on Thursday, and it closed today at 55.55. Tonight the WSJ touted AGN as a takeover target:

On Monday Allergan's shares rose 4%, sparking fresh questions about whether a deal could be in development. But with a market cap of $17 billion, some might consider the California-based Allergan a midsize target.

As advertised!!

No comments: